Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo And More By: Benzinga via Benzinga December 30, 2014 at 09:17 AM EST Neuroderm Ltd (NASDAQ: NDRM) +30% - The company announced favorable Phase IIa Parkinson’s treatment study results. China ... Read More >> Related Stocks: China Jojo Drugstore Idera Pharmaceuticals Kandi Techs Group Microsoft Procter & Gamble